Analysis of Results of Toxicological Examinations
however, New York qualitatively assayed for the presence of a total of 25 drugs. The number and type of drugs found per case varied. Methadone, for example, was found in 60% of the cases reported by New York and in 49% of the cases from Washington, D. C., but in only about 10% of cases reported by Philadelphia, Dallas. Miami, and San Francisco, and in less than 1 % of Los Angeles and Cleveland cases; it was not reported by Chicago. Phenmetrazine-caused deaths were reported only by Dallas (one case) and Washington, D. C. (29 cases) . From the data as a whole, information is presented for 33 drugs as to the concentration in physiological tissues and fluids. Analysis of single psychoactive drug cases and single-drug-plusethanol cases shows that, in the presence of ethanol, the toxic blood concentration of imipramine, amytriptyline, meprobamate, thioridazine, morphine, propoxyphene, methaqualone, and all barbiturates was decreased by an average of 50%. 
Methods of Data Collection
A collaborative working relationship was first established with the medical examiner or coroner in each of the nine cities and with his associated toxicological laboratory.
"Psychoactive drug-involved death" was defined as any death referred to a medical examiner or coroner in which psychoactive pharmacological agents were considered to be related to or involved in the fatal event. Ci.,..
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The toxicological laboratories of these cities tested for a total of 3909 drugs (1.95 per case). Of these, 2945 were quantitated, traces or no drugs were found in 159, and 805 drugs were simply reported as being present. Table 1 lists the type of result reported by the laboratory of each city. Definite patterns of toxicological examination clearly emerge. Washington, D. C., quantitated all of the drugs detected. In contrast, New York quantitated 33.8%, reported a qualitative "present" for 59.5%, and found a trace or no drug for 6.7% of the drugs that were tested for. The other cities lay somewhere between these two extremes. Qualitative presence was reported by Miami for 17%, by Philadelphia for 24.4%, and by Cleveland for 26% of their tested drugs. Chicago, Dallas, Los Angeles, and Washington reported a qualitative presence for less than 2% of their drugs. The same four cities reporting high percentages of drugs as qualitatively present also reported higher percentages of zero or traces found, as follows: Miami, 4.2%; Cleveland, 4.4%; New York, 6.7%; and Philadelphia, 14.2%.
The other five cities reported less than 2% zero or traces.
Another way to view these differences is to look at the number of quantitated drugs per case studied. of the cases in New York, Washington, and Philadelphia. These northeastern seaboard cities seemed to observe a very high incidence of methadoneand morphine-related cases, much more so than the rest of the participating cities. In contrast, Washington alone among the nine cities found a substantial number of cases of phenmetrazine-involved death, 20% of their cases. Washington and Philadelphia showed the greatest proportion of amphetamine-involved deaths. About 15% of the cases reported by these cities were found to involve amphetamine, whereas the average for the other cities was 1.2%.
One possible source of the differences would seem to be the drug-analysis methodology used by each city. If, for example, Los Angeles had used a more specific and accurate method for measuring morphine, and the other cities had used other, less-specific or less-reliable methods, this might explain the large representation of morphine-involved deaths in Los Angeles. Unfortunately, the methodologies used by the various cities for morphine assays were quite similar: gas-liquid chromatography predominated, followed by spectrofluorometry, immunoassays, fluorescent assays, and color tests. Perhaps the chief difference was not in the final assay method, but in earlier steps of the assays-in the extraction procedure, the extraction solvent, or the pH used in the extraction.
One can use gas-liquid chromatography to measure a drug after it has been concentrated from the specimen by a wide variety of extraction methods and solvents. Therefore, though the final assay methods were similar, the earlier steps might have been different. The answer to this question must await further data collection and analysis.
The other clear possibility is that these are genuine epidemiological differences. Table 4 lists in Part A the total number of drugs detected in various body tissues and fluids and the percent ofthe grand total for all sites. Ofthis total, 93% was on the blood, urine, bile, liver, or stomach contents. The frequency of tests on other body fluids or tissues depends largely on the city and on the drug in question.
Phenothiazines, amphetamine, metamphetamine, and quinine are preferentially assayed in urine; bile is the preferred specimen for morphine assays.
Part B of Some drugs were detected by the laboratory more often then they were listed as being involved in the death in another part of the form, indicating that in some instances the presence of a drug in body fluid or tissues was judged not to be a factor in the death.
The first three columns of Table 5 list the number of cases, the type of specimen studied, the mean concentration found, and the standard deviation of the concentration reported for these drugs. The large number of cases and the standard deviations presented in Table  5 add immeasurably to the usefulness of the data, giving a range-for some drugs a rather wide range-of toxic concentrations.
This table complements other tabulations of toxic concentrations (3, 4). The remainder of Table 5 gives data on the concentration of only those drugs that were found alone and the concentration of those drugs found in combination with alcohol. With the possible exception of diazepam, methadone, and glutethimide, all the other drugs when present alone show a higher toxic blood concentration than when they are present in combination with ethanol. Such synergism not only involves barbiturates, but also includes a great variety of drugs such as imipramme, amytriptyline, meprobamate, thioridazine, morphine (in blood and bile), propoxyphene, and methaqualone. The decrease in toxic concentration when the drug was present in combination with ethanol was usually considerable; only about half as great a concentration was toxic.
The exceptions noted above, upon further investigation and collection of data, may not really disagree with the trend. Diazepam, for example, appeared in these data in concentrations only slightly greater when in combination with alcohol than when alone, diazepam in combination with alcohol was reported in only five cases, and glutethimide in combination with alcohol in only three. Data on more cases may easily alter the pattern for these two drugs. Methadone is a different story: its concentration in blood when present in combination with ethanol was more than 20-fold that when it was present alone. The standard deviation for this combination is more than three times the mean, indicating a very wide range of results (Table 5) . On further inspection of these data, one finds that New York represents 70% of the cases of blood methadone reported, whether alone or in combination. New York, however, did not report assays for methadone in urine. The results for methadone in urine, alone and in combination with alcohol, contrast sharply with the results for blood. For all cities, the mean concentration of methadone in urine when present alone was 10.3 mg/liter (n = 27; SD = 11.9 mg/liter), but when methadone was present in combination with alcohol, the mean was 4.5 mg/liter (n = 13; SD = 2.7 mg/liter).
These results for urine imply that ethanol is toxicologically synergistic with methadone and that New York's large influence on the blood data obscures possible synergism in blood. In contrast to the pattern in drug combinations with alcohol, the concentration of a drug in blood when it is present alone or when in combination (Table 5 , first six columns) does not seem to follow any clear pattern.
A toxicology proficiency survey was done concurrently with the data collection (5). 
